A new immunoenzymatic assay (IEA) for the identification of Staphylococcus aureus strains of both human and animal origin was compared with rapid commercial kits. The sensitivities and specificities of the commercial kits varied from 90.2 to 96% and 90.8 to 93.7%, respectively. The IEA did not give any false-negative or false-positive results, while commercial kits gave high percentages of false-positive results among clumping factor-positive non-S. aureus strains. The IEA is particularly useful for isolates for which identification is doubtful, for large-scale epidemiological studies, and for identifying isolates from animals as S.
The most widely used assays for Staphylococcus aureus identification are the slide coagulase (COA) test for clumping factor (CF) detection and the tube COA test for staphylocoagulase (12) . More recently, several rapid systems for use in the identification of S. aureus have been introduced (1-4, 8, 12, 14, 15) ; they are based on the assumption that S. aureus isolates express either CF or protein A (PA). These tests provide results more rapidly than the tube COA test and are more accurate than the slide COA assay, although they fail to identify S. aureus strains negative for CF and PA, which represent up to 10 and 15% of S. aureus isolates, respectively (5, 12, 13, 16, 17, 22) . Moreover, because these kits are based on the detection of CF (12) , they can give false-positive results when non-S. aureus CF-positive strains are examined, i.e., S. lugdunensis (7), S. schleiferi subsp. schleiferi (7, 11) , and S. intermedius (10, 18) .
We have recently developed (9) a new immunoenzymatic assay (IEA) for S. aureus identification. The assay is based on a monoclonal antibody (MAb), MAb Cl-10/11, prepared against the S. aureus endo-o3-N-acetylglucosaminidase (SaG), an enzyme produced by all isolates of this species (19) (20) (21) .
This IEA was shown to be very accurate for identifying S. aureus because of the combined ability of the MAb to react with PA through the Fc fragment and with SaG through the Fab domains.
In the present work we analyzed the sensitivities of six commercially available rapid kits by studying a large number of S. aureus strains, including many isolates negative by the slide COA test, the tube COA test, the PA assay, or all three tests. We also evaluated the specificities of these kits by giving special attention to non-S. aureus strains of human and animal origin positive for CF and staphylocoagulase. Finally, we compared the reliabilities of these tests with that of the new IEA mentioned above.
Staphylococcal strains of both human and animal origin belonging to the collection of the Institute of Microbiology, Universities of Genova, Ancona, and Siena, were used. Strains were assigned to the various species by using standard biochemical tests (12) strains were described previously (9) . Strains of animal origin belonged to the species S. aureus, S. intermedius, S. hicus, S. equorum, S. schleifeni subsp. coagulans, and S.
delphini.
Bacterial strains were grown overnight in brain heart infusion agar (Difco Laboratories, Detroit, Mich.), collected with a toothpick, and spotted onto a nitrocellulose membrane; then, the IEA was performed as described previously (9) by using the anti-SaG Cl-10/11 MAb (10 ,tg ml-'). The tube COA test for staphylocoagulase, the slide test for CF, and the assay for protein A were performed as described previously (12, 17 (19) (20) (21) . The sensitivities of the commercial kits reported here were lower than those generally reported by other investigators for the same assays (1-4, 6, 8, 14, 15) ; this discrepancy could be because the number of strains negative by the slide COA test and the PA assay in the present study (Table 2 ) was greater than that tested in similar previous studies.
The 100% specificity of the IEA depends on the fact that SaG has chemical-physical properties that are different from those of the other staphylococcal bacteriolytic enzymes (19) (20) (21) . The lower specificity exhibited by the commercial kits (90.8 to 93.7%) depends on the fact that some staphylococcal species other than S. aureus produce CF. It must be pointed out that the specificities of the commercially avail- (1-4, 8, 14, 15) . This could be because previous reports did not include all the CF-positive, non-S. aureus strains that we examined in the present study (i.e., S. lugdunensis, S. intennedius, and S. schleifen subsp. schleiferi); as shown in Table 3 , the majority of these strains were erroneously identified as S. aureus by almost all commercial kits, and this accounts for the overall lower specificities that we obtained in comparison with those obtained in other studies.
Our data indicate that the IEA is the only reliable test for identifying strains as S. aureus, especially in veterinary diagnostic laboratories where S. internedius is frequently recovered. We are conducting studies to develop a MAb Cl-10/11-based commercial kit. The IEA execution time (4 h) is longer than those of the commercially available rapid kits; however, this time can be shortened by directly conjugating peroxidase to MAb Cl-10/11 and eliminating the use of labelled anti-mouse immunoglobulin. Moreover, since many strains can be blotted onto the nitrocellulose and tested with the antibodies, our test seems to be particularly useful when the simultaneous processing of a large number of strains is required, as in epidemiological studies.
In conclusion, while in medical microbiology laboratories the use of IEA is advisable for definitively identifying S. aureus strains with doubtful responses to traditional tests and for the simultaneous analysis of many isolates, this test has important applications in veterinary diagnostic laboratories, where it could be the major criterion for rapidly identifying S. aureus strains.
